Alpinetin prevents inflammatory responses in OVA-induced allergic asthma through modulating PI3K/AKT/NF-κB and HO-1 signaling pathways in mice
- 1 December 2020
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 89, 107073
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31772721)
This publication has 79 references indexed in Scilit:
- Eosinophilic Inflammation in Allergic AsthmaFrontiers in Pharmacology, 2013
- Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathyRedox Biology, 2013
- Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatiumOncology Reports, 2011
- Anti-Malarial Drug Artesunate Attenuates Experimental Allergic Asthma via Inhibition of the Phosphoinositide 3-Kinase/Akt PathwayPLOS ONE, 2011
- Recent Advances in Mechanisms and Treatments of Airway Remodeling in Asthma: A Message from the Bench Side to the ClinicThe Korean Journal of Internal Medicine, 2011
- Alveolar macrophages modulate allergic inflammation in a murine model of asthmaExperimental & Molecular Medicine, 2011
- Inhibition of IkB kinase and NF-κB by a novel synthetic compound SK 2009Bioorganic & Medicinal Chemistry, 2010
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- The NF- B Family of Transcription Factors and Its RegulationCold Spring Harbor Perspectives in Biology, 2009
- Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune systemJournal of Experimental Medicine, 2006